Evaluating a bacterial hypothesis in ibs using a modification of kochs postulates: Part 1

American Journal of Gastroenterology

Volumn 105, Issue 4, 2010, Pages 718-721

  Pimentel, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL OVERGROWTH; BACTERIUM CULTURE; CLINICAL EVALUATION; COLONY FORMING UNIT; ENTERITIS; GASTROINTESTINAL ENDOSCOPE; HUMAN; INTESTINE FLORA; MYCOBACTERIUM TUBERCULOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BREATH TESTS; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME;

EID: 77950477581     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.678     Document Type: Short Survey

References (27)

1. Hungin AP, Whorwell PJ, Tack J et al. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003;17:643-650
2. Agreus L, Svardsudd K, Nyren O et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671-680
3. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503-3506
4. Koch R. Die Aetiologie der Tuberkulose. Mittheilungen aus den Kaiserlichen Gesundheitsamte 1884;2:1-88.
5. Marshall BJ, Armstrong JA, McGechie DB et al. Attempt to fulfill Koch's postulates for pyloric Campylobacter. Med J Aust 1985;142:436-439
6. Marshall BJ. The discovery that Helicobacter pylori, a spiral bacterium, caused peptic ulcer disease. In: Marshall B (ed). Helicobacter Pioneers: Firsthand Accounts From the Scientists Who Discovered Helicobacters: 1892-1982. Blackwell Science Asia: Carlton, Victoria, Australia, 2002, pp 165-202.
7. Bardhan PK, Gyr K, Beglinger C et al. Diagnosis of bacterial overgrowth after culturing proximal small-bowel aspirate obtained during routine upper gastrointestinal endoscopy. Scand J Gastroenterol 1992;27:253-256
8. Khoshini R, Dai SC, Lezcano S et al. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2008;53:1443-1454
9. Bjorneklett A, Jenssen E. Relationships between hydrogen (H2) and methane (CH4) production in man. Scand J Gastroenterol 1982;17:985-992
10. Galatola G, Grosso M, Barlotta A et al. Diagnosis of bacterial contamination of the small intestine using the 1 g [14C] xylose breath test in various gastrointestinal diseases. Minerva Gastroenterol Dietol 1991;37:169-175
11. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo controlled study. Am J Gastroenterol 2003;98:412-419
12. Nucera G, Gabriella M, Lupascu A et al. Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2005;21:1391-1395
13. Esposito I, de Leone A, Di Gregorio G et al. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: an observation on non-absorbable antibiotics. World J Gastroenterol 2007;13:6016-6021
14. Madrid AM, Defilippi CC, Defillipi GC et al. Small intestinal bacterial overgrowth in patients with functional gastrointestinal diseases. Rev Med Chil 2007;135:1245-1252
15. Carrara M, Desideri S, Azzurro M et al. Small intestine bacterial overgrowth in patients with irritable bowel syndrome. Eur Rev Med Pharmacol Sci 2008;12:197-202.
16. Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008;103:958-963
17. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005;100:1566-1570
18. Lupascu A, Gabrielli M, Lauritano EC et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence casecontrol study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157-1160
19. McCallum R, Schultz C, Sostarich S. Evaluating the role of small intestinal bacterial overgrowth (SIBO) in diarrhea predominant irritable bowel syndrome (IBS-D) patients utilizing the glucose breath test (gbt) [abstr]. Gastroenterology 2005;128:A460.
20. Grover M, Kanazawa M, Palsson OS et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil 2008;20:998-1008.
21. Parodi A, Dulbecco P, Savarino E et al. Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution. J Clin Gastroenterol 2009;43:962-966
22. Soper GA. The work of a chronic typhoid germ distributor. JAMA 1907;48:2019-2022
23. Posserud I, Stotzer P-O, Björnsson ES et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007;56:802-808
24. Pimentel M, Park S, Kane SV et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557-563
25. Lembo A, Zakko SF, Ferreira NL et al. Rifaximin for the treatment of diarrhea-associated irritable bowel syndrome: short term treatment leading to long term sustained response [abstr]. Gastroenterology 2008;134:A545.
26. Sharara AI, Aoun E, Abdul-Baki H et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006;101:326-333
27. Lauritano EC, Gabrielli M, Scarpellini E et al. Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol 2008;103:2031-2035